These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21960232)

  • 21. Nephrolithiasis.
    Scheinman SJ
    Semin Nephrol; 1999 Jul; 19(4):381-8. PubMed ID: 10435676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi.
    McKee MD; Nanci A; Khan SR
    J Bone Miner Res; 1995 Dec; 10(12):1913-29. PubMed ID: 8619372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
    Ryall RL; Chauvet MC; Grover PK
    BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium kidney stones are associated with a haplotype of the calcium-sensing receptor gene regulatory region.
    Vezzoli G; Terranegra A; Arcidiacono T; Gambaro G; Milanesi L; Mosca E; Soldati L;
    Nephrol Dial Transplant; 2010 Jul; 25(7):2245-52. PubMed ID: 20067903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism of matrix Gla protein gene is associated with kidney stones.
    Gao B; Yasui T; Itoh Y; Tozawa K; Hayashi Y; Kohri K
    J Urol; 2007 Jun; 177(6):2361-5. PubMed ID: 17509359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of 3' vitamin D receptor haplotypes to urinary supersaturation of calcium oxalate salts and to age at onset and familial prevalence of nephrolithiasis.
    Mossetti G; Rendina D; Viceconti R; Manno G; Guadagno V; Strazzullo P; Nunziata V
    Nephrol Dial Transplant; 2004 Sep; 19(9):2259-65. PubMed ID: 15213319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India.
    Guha M; Bankura B; Ghosh S; Pattanayak AK; Ghosh S; Pal DK; Puri A; Kundu AK; Das M
    PLoS One; 2015; 10(6):e0130790. PubMed ID: 26107257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular mechanism of renal stone formation].
    Hamamoto S; Taguchi K; Fujii Y
    Clin Calcium; 2011 Oct; 21(10):1481-7. PubMed ID: 21960233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphism of vitamin D receptor gene start codon in patients with calcium kidney stones.
    Vezzoli G; Soldati L; Proverbio MC; Adamo D; Rubinacci A; Bianchi G; Mora S
    J Nephrol; 2002; 15(2):158-64. PubMed ID: 12018632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study.
    Borghi L; Meschi T; Amato F; Briganti A; Novarini A; Giannini A
    J Urol; 1996 Mar; 155(3):839-43. PubMed ID: 8583588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin D and calcium receptors: links to hypercalciuria.
    Bai S; Favus MJ
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):381-5. PubMed ID: 16775452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Functional evaluation in patients with kidney calculi].
    Stojimirović B
    Srp Arh Celok Lek; 1998; 126(9-10):394-8. PubMed ID: 9863414
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone disease in idiopathic hypercalciuria.
    Heilberg IP; Weisinger JR
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):394-402. PubMed ID: 16775454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the calcium-sensing receptor gene in idiopathic hypercalciuria and calcium nephrolithiasis.
    Petrucci M; Scott P; Ouimet D; Trouvé ML; Proulx Y; Valiquette L; Guay G; Bonnardeaux A
    Kidney Int; 2000 Jul; 58(1):38-42. PubMed ID: 10886547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.